eosinophilic bronchitis. exercise, cold air eosinophilic bronchitis airway hyperresponsiveness late...
TRANSCRIPT
Eosinophilic bronchitisEosinophilic bronchitis
Exercise, cold air
Eosinophilic bronchitis
Airway hyperresponsiveness
Late asthmatic reaction
Early asthmatic reaction
Allergen
Th2
IL-5IL-4Mast cell
Th2
Mast cell
Inflammation
Variable airflow
limitation
Chronic airflow
limitation
Symptoms
Airway hyperresponsiveness
Symptoms are nonspecificSymptoms are nonspecific
Other respiratory and non-respiratory conditions
Hargreave F, AAAAI 2006
Induced sputum in OA: usefulnessInduced sputum in OA: usefulness
• To identify occupational eosinophilic bronchitis (due to an allergen or chemical sensitizer) with or without asthma.
• This is done by serial measurements of induced sputum following periods at work and away from work.
• Eosinophils that increase at work and fall away from work indicate eosinophilic bronchitis.
• To support the diagnosis when the workplace sensitizer is unknown.
• To monitor airway inflammation before/after specific inhalation challenge (SIC).
Compatible clinical history
Asthma diagnosis• Reversible airflow
obstruction
• AHR
Work-relatednessSensitization • Skin prick tests
• Sepecific IgE
Methacholine test
+ –Still at work
No Asthma
No longer at work
SIC
+
Occupacional asthma
–
Return to work
SIC PEF monitoring
+–
Non-occupationalasthma
Chan-Yeung M, Malo JL. N Eng J Med 1995
Induced sputum
Changes in induced sputum after Changes in induced sputum after specific inhalation challengesspecific inhalation challenges
Lemière C et al. J Allergy Clin Immunol 2001;107:1063-8
Clinically significant increase: 0.26 x106 eosinophils/mL
bas 10 20 30 min 1h 2h 4h 6h 8h 10h 24h0
20
40
60
80
100
120
0
20
40
60
80
% Fall in FEV1 % eosinophils in sputum
PC20 methacholine > 16 mg/mlPC20 > 16 mg/ml
Latex-induced eosinophilic bronchitis
Allergen challenge
After budesonide 800 mcg/day one month
Latex 99 ng/m3 60 minutes
Quirce et al. JACI 2001
Normal Peak Expiratory Flow variability
200220240260280300320340360380400
1 2 3 4 5 6 7 8 9 10 11 12 13 14
MaximumMinimum
PEF L/min
Days at work
Eosinophilic bronchitisEosinophilic bronchitis• Isolated chronic cough, productive of sputum • Normal lung function without variable airflow limitation• Airway hyperresponsiveness absent • Eosinophilia in sputum and BAL • Cough reflex to capsaicin increased • Normal daily variability in peak expiratory flow (<20%)
• Upper airway symptoms are common • Middle age patients • Smoking is unusual• Prevalence of atopy similar to general population • Cough, sputum eosinophilia and cough reflex to capsaicin
improve with inhaled corticosteroids Gibson et al. Lancet 1989
Causes of isolated chronic coughCauses of isolated chronic cough
Primary Cause of Cough No. of patients (%)
Rhinitis 24Asthma 17.6Postviral 13.2
Eosinophilic bronchitis 13.2
Gastroesophageal reflux 7.7
Unexplained 6.6COPD 6.6Bronchiectasis 5.5
ACE inhibitor-induced cough 4.4
Lung cancer 2.2
Cryptogenic fibrosing alveolitis 1.1
Brightling CE et al. AJRCCM 1999
Asthma Eosinophilic bronchitis
Pathogenic mechanisms IgE-dependent
IgE-independent
Unknown
Allergic sensitization?
Clinical symptoms Dyspnea, cough, wheeze Isolated cough
Atopy Common Same as general population
Variable airflow obstruction Present Absent
Airway hyperresponsiveness Present Absent
Sputum eosinophilia Usually Always at diagnosis
Cough reflex
hypersensitivity
Normal or increased Increased
Bronchial biopsy
eosinophilic infiltration
Yes Yes
Bronchoalveolar lavage
eosinophilia
Yes Yes
Mast cell infiltration of
airway smooth muscle
Yes Absent
Brightling CE et al. N Eng J Med 2002
Microlocalization of mast cells in the Microlocalization of mast cells in the airway smooth muscle airway smooth muscle
A
D
C
B
0
2
4
6
8
10
12
Act
ivat
ed b
asop
hils
(%
)
Healthy controls
Eosinophilic bronchitis
Asthma
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
2E
osin
ophi
lic
prec
urso
rs (
%)
Healthy controls
Eosinophilic bronchitis
Asthma
0
2
4
6
8
10
12
Act
ivat
ed e
osin
ophi
ls C
D69
+ (
%)
Healthy controls
Eosinophilic bronchitis
Asthma
*
*
0
0,5
1
1,5
2
2,5
3
3,5
4
Act
ivat
ed e
osin
ophi
ls C
D25
+ (
%)
Healthy controls
Eosinophilic bronchitis
Asthma
*
*
Sastre B et al (submitted).
0
300
600
900
1200
1500
1800
PG
E2
in s
putu
m s
uper
nata
nt (
pg/m
l)
Healthy controls
Eosinophilic bronchitis
Asthma
*
†
0
50
100
150
200
250
300
350
LT
C4
in s
putu
m s
uper
nata
nt (
ng/m
l)
Healthy controls
Eosinophilic bronchitis
Asthma
†A B
PGEPGE22 LTCLTC44
Sastre B et al (submitted).
Diagnostic criteria for occupational Diagnostic criteria for occupational eosinophilic bronchitiseosinophilic bronchitis
• Isolated chronic cough (lasting more than 3 weeks) that worsens at work
• Sputum eosinophilia 3% in sputum
• Increases in sputum eosinophils are related to exposure to the offending agent (either at work or after SIC)
• Spirometric parameters are normal and are not significantly affected by exposure to the offending agent
• Absence of bronchial hyperresponsiveness to methacholine both at work and away from work
• Other causes of chronic cough are rule out.
Quirce S. Curr Opin Allergy Clin Immunol 2004;4:87-91
Causative agentCausative agent No. of No. of workers workers
ConfirmedConfirmed Author, yearAuthor, year
Tetrahydrophtalic anhydride
1 ? Kobayashi, 1994
Cyanoacrylate
Methacrylate
1 At/off work
SIC in the lab
Lemière, 1997
Latex 1 At/off work/SIC lab Quirce, 2001
Mushroom spores 3 (7.1%) At work Tanaka, 2002
Lysozyme 1 (4.7%) SIC in the lab Quirce, 2004
Welding fumes 1 At/off work/SIC lab Yacoub, 2005
Formaldehyde 1 SIC in the lab Yacoub, 2005
Chloramine T 1 SIC in the lab Krakowiak, 2005
Isocyanate (MDI) 1 At/off work/SIC lab Di Stefano, 2005
Cereal flour 1 Di Stefano, 2005
RemarksRemarks
• The examination of induced sputum should be part of the diagnostic algorithm for workers who complain of asthma-like symptoms in the workplace.
• Induced sputum is a diagnostic tool complementary to objective monitoring of lung function during periods at work and away from work, and before/after specific inhalation challenge
• Eosinophilic bronchitis (without asthma) should be regarded as an occupationally-induced condition when work related changes in sputum samples are significant and reproducible.
RecommendationsRecommendations• In patients with chronic cough due to nonasthmatic
eosinophilic bronchitis, – the possibility of an occupation-related cause needs to be considered.
(Level of evidence, expert opinion; benefit, substantial; grade of recommendation, E/A)
– when a causal allergen or occupational sensitizer is identified, avoidance is the best treatment. (Level of evidence, expert opinion; benefit, substantial; grade of recommendation, E/A)
– first line treatment is inhaled corticosteroids (except when a causal allergen or sensitizer is identified). Level of evidence low; benefit, substantial; grade of recommendation, B.
– If symptoms are persistently troublesome and/or the natural history of eosinophilic airway inflammation progresses despite treatment with high dose inhaled corticosteroids, oral corticosteroids should be given. (Level of evidence, expert opinion; benefit, substantial; grade of recommendation, E/A)
Brightling CE. Chest 2006;129:116S-21S
Park SW et al. Chest 2004
Follow-up of patients with EB after Follow-up of patients with EB after treatment with ICStreatment with ICS
Observational study of the natural Observational study of the natural history of eosinophilic bronchitishistory of eosinophilic bronchitis
• 52 patients with EB, 32 with follow-up 1 year• Mean duration of follow-up: 3.1 years (1-6 years)
– 3 patients developed asthma (9%)
– 5 patients FEV1/FVC (post-bd) <70% (16%)
– 1 complete resolution of cough and eosinophilia (3%)
– 13 persistent cough and eosinophilia >3% on one or more occasions (41%)
– 7 persistent cough and eosinophilia < 3% (22%)
– 3 symptom free and eosinophilia >3% occasionally (9%)
Berry MA et al. Clin Exp Allergy 2005
Not all cases of occupational Not all cases of occupational asthma are associated with asthma are associated with airway eosinophilia, and airway eosinophilia, and airway inflammation with airway inflammation with eosinophils may occur in the eosinophils may occur in the absence of asthmaabsence of asthma
Wardlaw AJ et al. Multidimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005;35:1254-62.
Wardlaw AJ et al. Multidimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005;35:1254-62.